Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05062863 · ClinicalTrials.gov registry record

An Observational Clinical Study of the T3 Dental Implant System

A clinical trial of Edentulous Jaw, sponsored by ZimVie.

Active
Registry status
140
Enrollment target
4
Study locations

NCT05062863 is a study of Edentulous Jaw that is active but no longer recruiting, run by ZimVie. The registered enrollment target is 140 participants. The trial reports 4 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05062863, a study of Edentulous Jaw, is active but no longer recruiting, sponsored by ZimVie.

ACTIVE NOT RECRUITING
Registry status
140 participants
Enrollment target
4
Study locations

Study Summary

This will be a prospective, observational study where all implants will be placed in either the maxilla or mandible and loaded immediately (within 48 hours), early (within 6-8 weeks) or delayed (\> 8 weeks) with a provisional or definitive prosthesis. The implants will be evaluated yearly for 2 years.

Conditions Studied

Interventions

  • DEVICE T3 dental implant system

Study Locations (4)

Florida

  • University of Florida - Gainesville

New Jersey

  • Jersey Shore University Medical Center - Neptune City

Virginia

  • Virginia Commonwealth University - Richmond

Other

  • Dr. Daniel Engler-Hamm - München

Trial Details

FieldValue
Enrollment Target 140 participants
Start Date 2021-10-20
Est. Completion 2026-08

Sponsor

ZimVie

10 total trials

What the Registry Record Tells You About NCT05062863

The ClinicalTrials.gov registry entry for NCT05062863 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ZimVie, which has 10 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Edentulous Jaw appearing as the primary indexed condition, and to 1 intervention - of which T3 dental implant system is the first listed.

NCT05062863 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Florida, New Jersey, Virginia.

Frequently Asked Questions

What is clinical trial NCT05062863 about?

NCT05062863 is a clinical study titled "An Observational Clinical Study of the T3 Dental Implant System". This will be a prospective, observational study where all implants will be placed in either the maxilla or mandible and loaded immediately (within 48 hours), early (within 6-8 weeks) or delayed (\> 8 weeks) with a provisional or definitive prosthesis. The implants will be evaluated yearly for 2 year...

What is the current status of trial NCT05062863?

This trial is currently active not recruiting. The enrollment target is 140 participants. The study started on 2021-10-20. Estimated completion is 2026-08.

What conditions does trial NCT05062863 study?

This clinical trial studies the following conditions: Edentulous Jaw.

What interventions are being tested in trial NCT05062863?

The interventions under investigation include: T3 dental implant system (DEVICE).

Who is sponsoring clinical trial NCT05062863?

This trial is sponsored by ZimVie, which has 10 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05062863 being conducted?

This trial has 4 study locations across Florida, New Jersey, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Edentulous Jaw

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.